Abbott Point of Care i-Stat Analyzer CPT - SFVAMC

This contract is a sole-source award issued under the VA National Acquisition Center (NAC) Federal Supply Schedule to Abbott Laboratories Inc. for the provision of i-STAT Point of Care analyzers and associated test cartridges, maintenance, and training to the VA San Francisco Health Care System. The base year runs from October 1, 2026, through September 30, 2027, with four optional one-year extension periods authorized through September 30, 2031, bringing the total potential contract value to $1,202,920.00, with a base year value of $240,584.00. The procurement operates under a Cost Per Test (CPT) pricing model, where Abbott provides the analyzer equipment at no upfront cost and is compensated solely based on the volume of test cartridges consumed annually, estimated at 19,800 units per year across seven FDA-approved test types including CG4+, CG8+, CHEM8+, Creatinine, ACTk, ACTc, and hs-Tnl. The award is justified under FAR 538.7104-3(b)(ii) due to the proprietary nature of Abbott’s i-STAT technology, the absence of authorized distributors, and the inability of any other vendor to meet the FDA-mandated specifications and performance requirements. Performance is to occur exclusively at the VA San Francisco Health Care System facility located at 4150 Clement Street in San Francisco, California. Contract administration is managed by the 261-NETWORK Contract Office 21 within the Department of Veterans Affairs, with no competitive evaluation conducted due to the non-competitive nature of the procurement. The contract includes FAR 52.217-8 to enable the option periods, and while packaging, inspection, invoicing, and payment details are not explicitly outlined, the arrangement is structured to ensure uninterrupted access to critical diagnostic capabilities for veteran care under an established and validated NAC contract vehicle.